Comparison of performance between three SARS‐CoV‐2 molecular assays (Aptima™, Laboratory Developed Test‐Fusion, and R‐GENE®) with special attention to turnaround time, a key point in laboratory management
Caroline Lefeuvre
(1, 2)
,
Adeline Pivert
(1)
,
Emilie Przyrowski
(3)
,
Elise Bouthry
(4)
,
Estelle Darviot
(2)
,
Rafaël Mahieu
(5, 2)
,
Françoise Lunel-Fabiani
(1)
,
Alexandra Ducancelle
(1)
,
Hélène Le Guillou-Guillemette
(2)
1
HIFIH -
Hémodynamique, Interaction Fibrose et Invasivité tumorales Hépatiques
2 CHU Angers - Centre Hospitalier Universitaire d'Angers
3 UA - Université d'Angers
4 World Health Organization Rubella National Reference Laboratory - Service de Virologie [Hôpital Paul-Brousse - APHP]
5 INCIT - Immunology and New Concepts in ImmunoTherapy
2 CHU Angers - Centre Hospitalier Universitaire d'Angers
3 UA - Université d'Angers
4 World Health Organization Rubella National Reference Laboratory - Service de Virologie [Hôpital Paul-Brousse - APHP]
5 INCIT - Immunology and New Concepts in ImmunoTherapy